Lung Cancer Small Cell Lung Cancer (SCLC)
6
0
0
1
Key Insights
Highlights
Success Rate
25% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
50.0%
3 terminated out of 6 trials
25.0%
-61.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
A Lay Navigation Intervention for Patients With Lung Cancer
The Effect of Pulmonary Rehabilitation on Pulmonary Function Tests, Exercise Capacity, and Quality of Life in Patients With Advanced-Stage Lung Cancer Receiving Chemotherapy
SERS-Based Serum Molecular Spectral Screening for Lung Cancer Type
Pulmonary Interstitial Lymphography in Early Stage Lung Cancer
Clinical and Pathologic Studies of Patients Undergoing Treatment With EGFR Inhibitors
Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors